Amgen Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. (AMGN) slipped 2.42% to $227.88 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.64% to 4,109.90 and Dow Jones Industrial Average falling 1.01% to 33,012.14.
The stock's fall snapped a two-day winning streak.
Amgen Inc. closed $68.79 below its 52-week high ($296.67), which the company reached on November 8th.
The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) fell 0.13% to $159.34 and Pfizer Inc. (PFE) fell 0.40% to $37.01.
Trading volume (2.6 M) eclipsed its 50-day average volume of 2.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 16, 2023.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 16, 2023 16:37 ET (20:37 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.